Dr. Peshek’s background and experience in TMS dates back to June of 2004. After completing his Psychiatry Residency at The University of Pennsylvania, he accepted a fellowship position in Mood & Anxiety Disorders at U Penn, where he worked on clinical trials in Neuromodulation, including the FDA-pivotal trial for TMS. Spark TMS was opened in October of 2018.
Transcranial Magnetic Stimulation was FDA-Approved in 2008 for treatment of major depression, 2013 for migraine and 2018 for OCD. The TMS protocol offered at Spark TMS is established for the patient under the direct supervision of Andrew Peshek, M.D.
Dr. Peshek has over 15 years of experience in the field of psychiatry. He obtained his medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio, and then completed his residency and fellowship at The University of Pennsylvania.
Dr. Peshek was determined to incorporate TMS therapy into his practice. Due to the growing demand for TMS therapy and the need to make this treatment available to patients outside of his own practice, Spark TMS was opened in October of 2018.
Dr. Peshek serves as medical director establishing the necessary TMS protocols for each patient. TMS therapy is not intended as a substitute for therapeutic counseling, but is rather an adjunct therapy in lieu or in addition to medication.
